Literature DB >> 14602852

Human-observer receiver-operating-characteristic evaluation of attenuation, scatter, and resolution compensation strategies for (99m)Tc myocardial perfusion imaging.

Manoj V Narayanan1, Michael A King, P Hendrik Pretorius, Seth T Dahlberg, Frederick Spencer, Ellen Simon, Eric Ewald, Edward Healy, Kirk MacNaught, Jeffrey A Leppo.   

Abstract

UNLABELLED: Nonuniform attenuation, scatter, and distance-dependent resolution are confounding factors inherent in SPECT imaging. Iterative reconstruction algorithms permit modeling and compensation of these degradations. We investigated through human-observer receiver-operating-characteristic (ROC) studies which (if any) combination of such compensation strategies best improves the accuracy of detection of coronary artery disease (CAD) when expert readers have only stress images for diagnosis.
METHODS: A 3-headed SPECT system fitted with a (153)Gd line source was used to acquire simultaneously (99m)Tc-methoxyisobutylisonitrile (MIBI) images and transmission data. With these acquisitions, the accuracy of detecting CAD was evaluated for the following reconstruction strategies: filtered backprojection (FBP); ordered-subset expectation maximization (OSEM) with attenuation correction (AC); OSEM with AC and scatter correction (SC) (AC + SC); and OSEM with AC, SC, and resolution compensation (RC) (AC + SC + RC). Reconstruction parameters for OSEM were optimized by use of human-observer ROC studies with hybrid images, whereas standard clinical parameters were used for FBP. A total of 100 patients, including 55 patients referred for angiography and 45 patients with <5% likelihood for CAD, were included in the ROC studies. Images reconstructed with the 4 methods were rated independently with regard to the presence of CAD by 7 observers using a continuous scale for certainty.
RESULTS: With area under the ROC curve (A(z)) as the criterion, the iterative reconstructions with compensation strategies (AC, AC + SC, and AC + SC + RC) demonstrated better detection accuracy than did FBP reconstructions for the overall detection of CAD as well as for the localization of perfusion defects in the 3 vascular territories. In general, the trend was for an increase in the A(z) for the progression from FBP to OSEM with AC, to OSEM with AC + SC, and to OSEM with AC + SC + RC. Statistically, the combination strategy with AC + SC + RC provided significantly higher A(z) values than did FBP images for the overall detection of CAD and the localization of perfusion defects in the left anterior descending coronary artery and left circumflex coronary artery territories, whereas AC + SC provided significantly better performance in the right coronary artery territory.
CONCLUSION: The results indicate that OSEM with AC + SC + RC outperforms FBP reconstructions, indicating that the modeling of physical degradations can improve the accuracy of detection of CAD with cardiac perfusion SPECT reconstructions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602852

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

1.  American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy.

Authors:  Gary V Heller; Jonathan Links; Timothy M Bateman; Jack A Ziffer; Edward Ficaro; Mylan C Cohen; Robert C Hendel
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

2.  ⁸²Rb PET myocardial perfusion imaging is superior to ⁹⁹mTc-labelled agent SPECT in patients with known or suspected coronary artery disease.

Authors:  Albert Flotats; Paco E Bravo; Kenji Fukushima; Muhammad A Chaudhry; Jennifer Merrill; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-31       Impact factor: 9.236

3.  Noise propagation in resolution modeled PET imaging and its impact on detectability.

Authors:  Arman Rahmim; Jing Tang
Journal:  Phys Med Biol       Date:  2013-09-13       Impact factor: 3.609

4.  Automated quantification of myocardial perfusion SPECT using simplified normal limits.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

5.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

6.  Diminishing the impact of the partial volume effect in cardiac SPECT perfusion imaging.

Authors:  P Hendrik Pretorius; Michael A King
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

7.  Evaluation of Rigid-Body Motion Compensation in Cardiac Perfusion SPECT Employing Polar-Map Quantification.

Authors:  P Hendrik Pretorius; Karen L Johnson; Michael A King
Journal:  IEEE Trans Nucl Sci       Date:  2016-06-24       Impact factor: 1.679

8.  Estimation of 6-Degree-of-Freedom (6-DOF) Rigid-Body Patient Motion From Projection Data by the Principal-Axes Method in Iterative Reconstruction.

Authors:  Bing Feng; Michael A King
Journal:  IEEE Trans Nucl Sci       Date:  2006-11       Impact factor: 1.679

9.  Investigation of the physical effects of respiratory motion compensation in a large population of patients undergoing Tc-99m cardiac perfusion SPECT/CT stress imaging.

Authors:  P Hendrik Pretorius; Karen L Johnson; Seth T Dahlberg; Michael A King
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

10.  A postprocessing method for compensation of scatter and collimator blurring in SPECT: a proof-of-concept study.

Authors:  Yan Yan; Gengsheng Lawrence Zeng
Journal:  J Nucl Med Technol       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.